ArticleRheumatology and therapy2020

Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.